Please login to the form below

Not currently logged in
Email:
Password:

Metrics appoints director of pharma development

Promotion for Joseph Cobb at contract development and manufacturing organisation

Joseph Cobb has been named as the director of pharmaceutical development at the US contract development and manufacturing company Metrics.

The appointment is a promotion for Cobb, who has been with North Carolina-based Metrics since 2002, serving most recently as associate director of pharmaceutical development.

In his new role, Cobb will oversee Metrics' work in early-phase solid oral dosage development, as well as the company's potent and cytotoxic drug development services.

These services cover pharmaceutical formulation development; first-time- in-man formulations; and the manufacturing of clinical materials for trials covering phase I to III.

“Joe is a smart and capable leader who has been instrumental in guiding the success and growth of Metrics' formulation development capabilities,” said Phil Hodges, president of the company, which operates as a subsidiary of Mayne Pharma.

“With these new responsibilities, Joe will bring to his role the same thoughtfulness and resourcefulness.”

7th February 2013

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Page & Page

For those who can imagine better, Page & Page is home to meaningful encounters of a marketing, communication and creative kind:...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics